Microlearning: All the Small Things - Insights
As the saying often goes, “It’s the small things that matter the most.” Jeremy Zacher, Education Specialist in the Department of Laboratory Medicine and Pathology, discusses "microlearning" as a way of delivering learning content in...
A letter of appreciation, which was forwarded to Mayo Clinic President and CEO John Noseworthy, M.D., and Board of Trustees member Samual Di Piazza, Jr., described the outstanding contributions to science and education that Mayo Clinic DLMP...
Mayo's Own American Ninja Warrior Returns to Competition - Insights
Age seems to slow most people down. But Andrew Yori, a.k.a. the K9 Ninja who competed in the "American Ninja Warrior" competition, isn't like most people. While Andrew didn't win, he did achieve raising awareness of shelter dogs and their...
Plummer Building #ThrowbackThursday - Insights
Opened in 1928, the Plummer Building is an iconic symbol of Mayo Clinic, designated as a National Historic Landmark. It is named for Henry S. Plummer, M.D., the “diversified genius” who designed it and who created many of the systems and...
In an article about "titans who defined a new era in business during the last decade," former Mayo Clinic President and CEO John Noseworthy, M.D., looked back on his tenure with gratitude.
Earth Day, Saturday, April 22, is one day when most folks pay particularly close attention to protecting the environment. This year, we're finding inspiration in the Sisters of Saint Francis who helped raise money for the Poverello Fund by...
Research Archives - Page 8 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 9 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 8 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 10 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 24 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 23 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Turkey Tips for Thanksgiving - Insights
Preparing a Thanksgiving turkey can prove tricky for even the most experienced cooks. How big of a bird to select, how to thaw it in time, and how to avoid undercooking, overcooking or—even worse—food poisoning, are among the challenges...
Sparrow Health System has chosen Mayo Medical Laboratories as its primary reference laboratory for advanced laboratory testing, enhancing the availability of complex tests and making test results available more quickly to providers and...
Mayo Medical Laboratories and National University Hospital (NUH) in Singapore are now electronically linked via the widely used and secure Health Level 7 interface, enabling NUH to order specialized Mayo laboratory tests and receive patient...
Hunting Accident Leads to Memorable Mayo Experience #ThrowbackThursday - Insights
This story was told by Gary and Virginia Chalberg of Kingman, Arizona, who were visiting family at Mayo Clinic Hospital in Phoenix. While there, Gary, 84, asked if he could share the story of his dad’s first patient experience at Mayo...
The Mayos and Their Motorcars #ThrowbackThursday - Insights
Electric or gas-powered? It’s a question that drivers ponder as they weigh options for what kind of car to purchase. Charles Mayo, M.D., wrestled with a similar issue at the dawn of the 20th century. Moreover, Dr. Charlie had to consider...
Week in Review: April 22 - Insights
Today's highlights include: Study mines cancer genetics to help with targeted treatment, Mayo Clinic to launch staffing tool app to find 'right nurse for the right role', and new blood biomarker may lead to early diagnosis of frontotemporal...
Week in Review: May 6 - Insights
Today's highlights include: Mental health needs rise as pandemic fluctuates, an algorithm that analyzes apple watch data shows early promise in detecting heart problems, and Minnesota physicians brace for Roe v. Wade decision
Mayo Clinic Laboratory and pathology research roundup: January 25 - Insights
Today's Topic Features: Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib.
Mayo Clinic Laboratory and Pathology Research Roundup: March 11 - Insights
This week’s Research Roundup highlights an assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients and several other research articles by Mayo Clinic physicians...
Comprehensive genetic analysis for sarcoma fusions - Insights
Sarcomas are malignant tumors that arise in the bone and soft tissue. With numerous subtypes of sarcoma that can have overlapping histological, immunophenotypic, and clinical features, diagnosis can be extremely challenging
Pathways Case Studies: April 2020 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for April include the following sub-specialties: Gastroenterology & Surgical,...
Pathways Case Studies: November 2019 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for November include the following sub-specialties: Cytogenetics, Genetics,...
Pathways Case Studies: May 2020 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for May include the following sub-specialties: Bone and Soft Tissue & Infectious...
Pathways Case Studies: January 2020 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for January include the following sub-specialties: bone and soft tissue, cellular...
Pathways Case Studies: December 2019 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for December include the following sub-specialties: Biochemical Genetics, Bone and...
Endocrinology Testing - Mayo Clinic Laboratories
Standardization of procedures and protocols is essential for the reliable interpretation of dynamic endocrine testing results. Our test menu includes more than 70 common and esoteric analytes and is constantly growing.
Activity Metrics Dashboard - Insights
We are excited to share that the Activity Metrics Dashboard is now live on mayocliniclabs.com. We heard your feedback and created these reports to provide a more integrated, intuitive and customized experience on our website.
Primary ciliary dyskinesia - Insights
Learn more about Mayo Clinic Laboratories’ robust approach to testing for primary ciliary dyskinesia, a rare genetic condition that can lead to chronic otosinopulmonary disease and infertility in men.
Learn more about how carrier screening at Mayo Clinic Laboratories can provide prospective parents with a personalized risk assessment of bearing a child with certain inherited conditions.
Learn more about how Mayo Clinic Laboratories’ testing can assist in diagnosis and differentiation of porphyrias and help guide treatment decisions
Browse our full menu of testing for motor and sensory neuropathies, spastic paraplegia, amyloidosis, and brachial plexus, among other conditions.
Organic acid disorders - Insights
Check out how Mayo Clinic Laboratories testing for organic acid metabolism disorders can help provide early diagnosis that enable prompt intervention.
Amino acid disorders - Insights
Learn more about how amino acid metabolism testing at Mayo Clinic Laboratories can assist in diagnosing the most preventable and treatable amino acid disorders.
Tick-borne coinfection - Insights
Browse our suite of serological and molecular testing designed to detect tick-borne pathogen coinfections.
Effective testing is vitally important for diagnosis, prognosis, and disease management. With more than 90% of the 7,000 identified rare diseases lacking FDA-approved treatment,1 and patients waiting between 8 and 10 years before diagnosis,...
Mayo Clinic Laboratories’ BioPharma Diagnostics team facilitates customized collaborations with diagnostic companies to support their clinical and research testing needs.
Monogenic IBD Testing - Mayo Clinic Laboratories
Monogenic inflammatory bowel disease (IBD) refers to a diverse spectrum of rare genetic disorders that present with intestinal inflammation. The majority of patients with monogenic IBD, unlike those with polygenic IBD, show symptoms before...
Confirmatory testing - Insights
Use of mass spectrometry technology in Mayo Clinic Laboratories’ confirmatory drug testing enables accurate identification of parent drugs and metabolites, equipping providers with confidence about their patients’ drug use.
Hereditary causes of kidney stones - Insights
Learn about our kidney stone panel, which assesses 72 genes associated with inherited conditions that can lead to stone development.
Newborn Screening at Mayo Clinic Laboratories
Newborn screening is intended to detect serious health conditions in babies for which early intervention can greatly improve healthy development and positive outcomes.
Clinical and forensic toxicology - Insights
Clinical, forensic, and emergency toxicology testing at Mayo Clinic Laboratories, which aligns with evidence-based clinical laboratory guidelines, uses advanced and emerging technologies and is performed on urine, serum, and meconium...
Autoimmune Myelopathy Testing - Mayo Clinic Laboratories
Mayo Clinic Laboratories is the only laboratory in the world to offer testing for a novel form of autoimmune meningoencephalomyelitis.
We offer next-generation sequencing and comprehensive fluorescence in situ hybridization (FISH) panels, as well as extensive immunohistochemistry (IHC) offerings, to diagnose and monitor T-cell lymphoma.
Learn about our comprehensive MayoComplete solid tumor panel, which analyzes 515 genes for mutations, rearrangements, and amplifications.
Lung Cancer NGS Panel - Mayo Clinic Laboratories
Our targeted lung cancer panel assesses for mutations in eight genes, and rearrangements in four genes, including those recommended by the National Comprehensive Cancer Network: EGFR, ROS1, BRAF, and ALK.
Browse our menu of MayoComplete next-generation sequencing assays which are designed to identify a growing list of hematological cancers.
Thrombotic microangiopathy (TMA) - Insights
View our comprehensive testing suite designed to confirm diagnosis and facilitate treatment of thrombotic microangiopathy.
Learn how our melanoma testing identifies variants in 17 genes associated with diagnosis, prognosis, and treatment guidance.